Telomere Shortening Occurs in Subsets of Normal Breast Epithelium as well as in Situ and Invasive Carcinoma

American Journal of Pathology

Volumn 164, Issue 3, 2004, Pages 925-935

  Meeker, Alan K ^a,b   Hicks, Jessica L ^b   Gabrielson, Edward ^a   Strauss, William M ^c   De Marzo, Angelo M ^a,b   Argani, Pedram ^a,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST TUMOR; CARCINOMA IN SITU; CHROMOSOMAL PARAMETERS; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SECRETORY CELL; TELOMERE;

EID: 1242338876     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63180-X     Document Type: Article

References (45)

1. Blasco MA: Telomerase beyond telomeres. Nat Rev Cancer 2002, 2:627-633
2. Kim SH, Kaminker P, Campisi J: Telomeres, aging and cancer: in search of a happy ending. Oncogene 2002, 21:503-511
3. Hackett JA, Greider CW: Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 2002, 21:619-626
4. Autexier C, Greider CW: Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci 1996, 21:387-391
5. Artandi SE, DePinho RA: A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 2000, 10:39-46
6. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, Mitelman F, Mertens F, Mandahl N: Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 2001, 98:12683-12688
7. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA: Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645
8. von Zglinicki T: Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344
9. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346:866-868
10. Furugori E, Hirayama R, Nakamura KI, Kammori M, Esaki Y, Takubo K: Telomere shortening in gastric carcinoma with aging despite telomerase activation. J Cancer Res Clin Oncol 2000, 126:481-485
11. Mehle C, Ljungberg B, Roos G: Telomere shortening in renal cell carcinoma. Cancer Res 1994, 54:236-241
12. Takagi S, Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takahashi S, Negoro K, Shimosegawa T, Toyota T: Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer 1999, 86:1431-1436
13. Rogalla P, Rohen C, Bonk U, Bullerdiek J: Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers. Cancer Lett 1996, 106:155-161
14. Rha SY, Park KH, Kim TS, Yoo NC, Yang WI, Roh JK, Min JS, Lee KS, Kim BS, Choi JH, Lim HY, Chung HC: Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast. Int J Oncol 1999, 15:839-845
15. Griffith JK, Bryant JE, Fordyce CA, Gilliland FD, Joste NE, Moyzis RK: Reduced telomere DNA content is correlated with genomic instability and rnetastasis in invasive human breast carcinoma. Breast Cancer Res Treat 1999, 54:59-64
16. Odagiri E, Kanada N, Jibiki K, Demura R, Aikawa E, Demura H: Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 1994, 73:2978-2984
17. Meeker AK, Gage WR, Hicks JL, Simon I, Coffman JR, Platz EA, March GE, De Marzo AM: Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am J Palhol 2002, 160:1259-1268
18. Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, Delannoy MJ, De Marzo AM: Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 2002, 62:6405-6409
19. van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GJ, Hicks JL, Wilentz RE, Goggins MG, De Marzo AM, Hruban RH, Maitra A: Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002, 161:1541-1547
20. Chen C, Hong YK, Ontiveros SD, Egholm M, Strauss WM: Single base discrimination of CENP-B repeats on mouse and human Chromosomes with PNA-FISH. Mamm Genome 1999, 10:13-18
21. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS: Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284
22. Rosen PP: Rosen's Breast Pathology. Philadelphia, Lippincott Williams and Wilkins, 2001
23. Page DL, Anderson, TJ: Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 1987
24. Gisselsson D, Bjork J, Hoglund M, Mertens F, Dal Cin P, Akerman M, Mandahl N: Abnormal nuclear shape in solid tumors reflects mitotic instability. Am J Pathol 2001, 158:199-206
25. Buerger H, Simon R, Schafer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Bocker W: Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000, 53:118-121
26. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W: Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999, 189:521-526
27. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC: Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998, 90:697-703
28. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K: Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 2003, 1:362-375
29. Lodato RF, Maguire HC Jr, Greene MI, Weiner DB, LiVoisi VA: Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol 1990, 3:449-454
30. Umbricht CB, Sherman ME, Dome J, Carey LA, Marks J, Kim N, Sukumar S: Telomerase activity in ductal carcinoma in situ and invasive breast cancer. Oncogene 1999, 18:3407-3414
31. Ramakrishnan R, Khan SA, Badve S: Morphological changes in breast tissue with menstrual cycle. Mod Pathol 2002, 15:1348-1356
32. Joshi K, Smith JA, Perusinghe N, Monoghan P: Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells. Am J Pathol 1986, 124:199-206
33. Meyer JS, Connor RE: Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling. Cancer 1982, 50:746-751
34. Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA, Gerald WL: Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat Genet 1998, 19:182-186
35. Romanov SR, Kozakiewicz BK, Holst CR, Stampfer MR, Haupt LM, Tlsty TD: Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001, 409:633-637
36. Holst CR, Nuovo GJ, Esteller M, Chew K, Baylin SB, Herman JG, Tlsty TD: Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 2003, 63:1596-1601
37. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996, 274:2057-2059
38. Larson PS, de las Morenas A, Bennett SR, Cupples LA, Rosenberg CL: Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol 2002, 161:283-290
39. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S: Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68:3410-3414
40. Reddel RR: Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett 2003, 194:155-162
41. Tsao JI, Zhao YL, Lukas J, Yang XW, Shah A, Press M, Shibata D: Telomerase activity in normal and neoplastic breast. Clin Cancer Res 1997, 3:627-631
42. Mueller C, Riese U, Kosmehi H, Dahse R, Claussen U, Ernst G: Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome. Int J Oncol 2002, 20:385-390
43. Wullich B, Rohde V, Oehlenschlager B, Bonkhoff H, Ketter R, Zwergel T, Sattler HP: Focal intratumoral heterogeneity for telomerase activity in human prostate cancer. J Urol 1999, 161:1997-2001
44. von Zglinicki T: Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 2000, 908:99-110
45. Shay JW, Wright WE: Telomerase: a target for cancer therapeutics. Cancer Cell 2002, 2:257-265